Clinical Trial Update: Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring glycine metabolism mutation neurobiology in psychotic disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder

Snippet

Sponsor: Mclean Hospital | Conditions: Schizo-affective Disorder, Bipolar Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-04-18